BamSEC and AlphaSense Join Forces
Learn More

Champions Oncology Inc.

NASDAQ: CSBR    
Share price (11/22/24): $4.55    
Market cap (11/22/24): $61.9 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.3
from 8-K 3 pages Option Exchange Agreement
12/34/56
EX-10.2
from 8-K 3 pages Option Exchange Agreement
12/34/56
EX-10.1
from 8-K 4 pages Option Exchange Agreement
12/34/56
EX-10.11
from S-1 15 pages Warrant to Purchase Common Stock of Champions Oncology, Inc
12/34/56
EX-10.6
from 8-K 1 page Champions Oncology, Inc. March 16, 2015
12/34/56
EX-10.5
from 8-K 1 page Champions Oncology, Inc. March 16, 2015
12/34/56
EX-10.4
from 8-K 3 pages Option Exchange Agreement
12/34/56
EX-10.3
from 8-K 3 pages Option Exchange Agreement
12/34/56
EX-10.2
from 8-K 3 pages Option Exchange Agreement
12/34/56
EX-10.1
from 8-K 3 pages Option Exchange Agreement
12/34/56
EX-10.6
from 8-K 3 pages Amendment No. 1 to 2013 Warrants to Purchase Common Stock of Champions Oncology, Inc
12/34/56
EX-10.5
from 8-K 3 pages Amendment No. 1 to 2011 Warrants to Purchase Common Stock of Champions Oncology, Inc
12/34/56
EX-10.4
from 8-K 36 pages Amended and Restated 2013 Securities Purchase Agreement
12/34/56
EX-10.3
from 8-K 34 pages Amended and Restated 2011 Securities Purchase Agreement
12/34/56
EX-10.2
from 8-K 14 pages Champions Oncology, Inc. Warrant
12/34/56
EX-10.1
from 8-K 40 pages 2015 Amended and Restated Registration Rights Agreement
12/34/56
EX-10.1
from 8-K 75 pages Securities Purchase Agreement
12/34/56
EX-10.2
from 8-K 1 page Amendment No. 1 to Convertible Promissory Note
12/34/56
EX-10.1
from 8-K 1 page Amendment No. 1 to Convertible Promissory Note
12/34/56
EX-10.2
from 8-K 7 pages Champions Oncology, Inc. Convertible Promissory Note Issue Date: December 1, 2014
12/34/56